With FDA Clearance at Hand for CF IVD, Osmetech Plans New Products, Starts to Build a Sales Force | GenomeWeb

The US Food and Drug Administration's 510(k) clearance in January of a cystic fibrosis carrier-detection assay on Osmetech's eSensor 4800 DNA Detection platform came six months after the company acquired the technology from Motorola.

The clearance, which Osmetech plans to follow in the second quarter with a launch, also places the company ahead of other array companies whose own assays are currently queuing at the FDA, including Spectral Genomics and PathWork Informatics (see BAN 1/24/2006).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.